Literature DB >> 28349652

Normal IQ is possible in Smith-Lemli-Opitz syndrome.

Yasemen Eroglu1, Mina Nguyen-Driver1,2, Robert D Steiner1,2,3,4, Louise Merkens1, Mark Merkens1, Jean-Baptiste Roullet1,5, Ellen Elias6, Geeta Sarphare7, Forbes D Porter8, Chumei Li9, Elaine Tierney7, Małgorzata J Nowaczyk9, Kurt A Freeman1,2.   

Abstract

Children with Smith-Lemli-Opitz syndrome (SLOS) are typically reported to have moderate to severe intellectual disability. This study aims to determine whether normal cognitive function is possible in this population and to describe clinical, biochemical and molecular characteristics of children with SLOS and normal intelligent quotient (IQ). The study included children with SLOS who underwent cognitive testing in four centers. All children with at least one IQ composite score above 80 were included in the study. Six girls, three boys with SLOS were found to have normal or low-normal IQ in a cohort of 145 children with SLOS. Major/multiple organ anomalies and low serum cholesterol levels were uncommon. No correlation with IQ and genotype was evident and no specific developmental profile were observed. Thus, normal or low-normal cognitive function is possible in SLOS. Further studies are needed to elucidate factors contributing to normal or low-normal cognitive function in children with SLOS.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  IQ; Smith-Lemli-Opitz; development

Mesh:

Substances:

Year:  2017        PMID: 28349652      PMCID: PMC6016830          DOI: 10.1002/ajmg.a.38125

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

Review 1.  Cholesterol metabolism in the brain.

Authors:  J M Dietschy; S D Turley
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

2.  Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease.

Authors:  C Mueller; S Patel; M Irons; K Antshel; G Salen; G S Tint; C Bay
Journal:  Am J Med Genet A       Date:  2003-11-15       Impact factor: 2.802

3.  Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.

Authors:  Darryn M Sikora; Mark Ruggiero; Kersti Petit-Kekel; Louise S Merkens; William E Connor; Robert D Steiner
Journal:  J Pediatr       Date:  2004-06       Impact factor: 4.406

4.  Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS).

Authors:  D Haas; S F Garbade; C Vohwinkel; N Muschol; F K Trefz; J M Penzien; J Zschocke; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-05-11       Impact factor: 4.982

5.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.

Authors:  H R Waterham; F A Wijburg; R C Hennekam; P Vreken; B T Poll-The; L Dorland; M Duran; P E Jira; J A Smeitink; R A Wevers; R J Wanders
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

6.  Cholesterol metabolism and placental transfer in the pregnant Rhesus monkey.

Authors:  R M Pitkin; W E Connor; D S Lin
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

7.  Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome.

Authors:  M Witsch-Baumgartner; M Gruber; H G Kraft; M Rossi; P Clayton; M Giros; D Haas; R I Kelley; M Krajewska-Walasek; G Utermann
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

8.  Maternal ABCA1 genotype is associated with severity of Smith-Lemli-Opitz syndrome and with viability of patients homozygous for null mutations.

Authors:  Barbara Lanthaler; Elisabeth Steichen-Gersdorf; Barbara Kollerits; Johannes Zschocke; Martina Witsch-Baumgartner
Journal:  Eur J Hum Genet       Date:  2012-08-29       Impact factor: 4.246

9.  Cholesterol metabolism is required for intracellular hedgehog signal transduction in vivo.

Authors:  Rolf W Stottmann; Annick Turbe-Doan; Pamela Tran; Lisa E Kratz; Jennifer L Moran; Richard I Kelley; David R Beier
Journal:  PLoS Genet       Date:  2011-09-01       Impact factor: 5.917

10.  Cholesterol: its regulation and role in central nervous system disorders.

Authors:  Matthias Orth; Stefano Bellosta
Journal:  Cholesterol       Date:  2012-10-17
View more
  1 in total

1.  Auditory phenotype of Smith-Lemli-Opitz syndrome.

Authors:  Christopher K Zalewski; Sarah A Sydlowski; Kelly A King; Simona Bianconi; An Dang Do; Forbes D Porter; Carmen C Brewer
Journal:  Am J Med Genet A       Date:  2021-02-02       Impact factor: 2.578

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.